Satoru Joshita

5.0k total citations · 1 hit paper
120 papers, 2.9k citations indexed

About

Satoru Joshita is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Satoru Joshita has authored 120 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 74 papers in Hepatology and 26 papers in Surgery. Recurrent topics in Satoru Joshita's work include Liver Disease Diagnosis and Treatment (69 papers), Liver Diseases and Immunity (35 papers) and Hepatitis C virus research (26 papers). Satoru Joshita is often cited by papers focused on Liver Disease Diagnosis and Treatment (69 papers), Liver Diseases and Immunity (35 papers) and Hepatitis C virus research (26 papers). Satoru Joshita collaborates with scholars based in Japan, United States and India. Satoru Joshita's co-authors include Takeji Umemura, Eiji Tanaka, Akihiro Matsumoto, Masao Ôta, Michiharu Komatsu, Kaname Yoshizawa, Takefumi Kimura, Tetsuya Ichijo, Naoki Tanaka and Tomoo Yamazaki and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Satoru Joshita

115 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development

2018 464 citations Ilia D. Vainchtein, Gregory Chin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoru Joshita Japan	29	1.5k	1.3k	647	536	475	120	2.9k
Hiroyuki Nakashima Japan	31	451 0.3×	276 0.2×	788 1.2×	391 0.7×	104 0.2×	111	2.7k
Shinya Sato Japan	23	410 0.3×	305 0.2×	274 0.4×	238 0.4×	102 0.2×	102	1.9k
Jonathan A. Dranoff United States	29	877 0.6×	1.1k 0.8×	151 0.2×	922 1.7×	41 0.1×	69	2.7k
Yinghua Tian Switzerland	23	682 0.5×	1.2k 0.9×	327 0.5×	1.2k 2.2×	32 0.1×	49	2.5k
Scot D. Henry United States	19	470 0.3×	1.0k 0.8×	146 0.2×	1.0k 1.9×	266 0.6×	26	2.3k
A Bergk Germany	16	931 0.6×	892 0.7×	163 0.3×	50 0.1×	101 0.2×	25	1.6k
Stefan Schob Germany	25	469 0.3×	91 0.1×	264 0.4×	183 0.3×	115 0.2×	101	2.1k
Samar H. Ibrahim United States	25	1.7k 1.1×	811 0.6×	297 0.5×	454 0.8×	16 0.0×	54	3.0k
Toshikazu Gondo Japan	27	384 0.3×	134 0.1×	181 0.3×	411 0.8×	104 0.2×	98	2.0k
Xiaofeng Wu China	24	218 0.1×	218 0.2×	339 0.5×	202 0.4×	90 0.2×	105	2.0k

Countries citing papers authored by Satoru Joshita

Since Specialization

Citations

This map shows the geographic impact of Satoru Joshita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Joshita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Joshita more than expected).

Fields of papers citing papers by Satoru Joshita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Joshita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Joshita. The network helps show where Satoru Joshita may publish in the future.

Co-authorship network of co-authors of Satoru Joshita

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Joshita. A scholar is included among the top collaborators of Satoru Joshita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Joshita. Satoru Joshita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Atsushi, Hiromasa Ohira, Kazumichi Abe, et al.. (2024). Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease. Internal Medicine. 64(3). 337–342. 1 indexed citations

Kimura, Takefumi, Ayumi Sugiura, Hiroyuki Kobayashi, et al.. (2024). Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy. Journal of Viral Hepatitis. 32(4). e14025–e14025. 2 indexed citations

Kimura, Takefumi, Tomoo Yamazaki, Hamim Zafar, et al.. (2023). Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease. Liver International. 44(2). 483–496. 12 indexed citations

Joshita, Satoru, Hiroyuki Kobayashi, Yūki Yamashita, et al.. (2023). Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients. Journal of Viral Hepatitis. 30(9). 731–739. 4 indexed citations

Ôta, Masao, Yasunari Fujinaga, Makiko Ozawa, et al.. (2022). The levels of IL-1β and soluble IL-1 receptors in patients with IgG4-related periaortitis/periarteritis. Advances in Medical Sciences. 67(2). 257–261. 1 indexed citations

Fujimori, Naoyuki, Takefumi Kimura, Naoki Tanaka, et al.. (2022). 2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease. Hepatology Research. 52(4). 352–363. 9 indexed citations

Yamashita, Yūki, Takeji Umemura, Takefumi Kimura, et al.. (2022). Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis. JHEP Reports. 5(4). 100662–100662. 8 indexed citations

Kimura, Takefumi, Naoki Tanaka, Tomoo Yamazaki, et al.. (2022). Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD. Biomedicines. 10(11). 2806–2806. 8 indexed citations

Joshita, Satoru, Kazuhiro Kimura, Hirohiko Motoki, et al.. (2021). Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease. PLoS ONE. 16(4). e0249435–e0249435. 1 indexed citations

10.

Yamashita, Yūki, Satoru Joshita, Ayumi Sugiura, et al.. (2021). aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C. Hepatology Research. 51(9). 933–942. 15 indexed citations

11.

Joshita, Satoru, Yūki Yamashita, Toru Okamoto, et al.. (2021). Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct‐acting antivirals. Hepatology Research. 51(7). 758–766. 3 indexed citations

12.

Joshita, Satoru, Takeji Umemura, Yūki Yamashita, et al.. (2019). Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis. Hepatology Research. 49(10). 1236–1243. 29 indexed citations

13.

Saito, Hiromi, Takeji Umemura, Satoru Joshita, et al.. (2018). Association between KIR-HLA combination and ulcerative colitis and Crohn’s disease in a Japanese population. PLoS ONE. 13(4). e0195778–e0195778. 22 indexed citations

14.

Vainchtein, Ilia D., Gregory Chin, Frances S. Cho, et al.. (2018). Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science. 359(6381). 1269–1273. 464 indexed citations breakdown →

15.

Komatsu, Michiharu, Naoki Tanaka, Takefumi Kimura, et al.. (2018). Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patients. Hepatology Research. 48(13). 1092–1098. 14 indexed citations

16.

Yamazaki, Tomoo, Satoru Joshita, Takeji Umemura, et al.. (2018). Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C. PLoS ONE. 13(4). e0195632–e0195632. 13 indexed citations

17.

Umemura, Takeji, Tomoo Yamazaki, Satoru Joshita, et al.. (2018). Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C. Cytokine. 111. 357–363. 4 indexed citations

18.

Joshita, Satoru, Yuki Ichikawa, Takeji Umemura, et al.. (2017). Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatology Research. 48(4). 275–285. 31 indexed citations

19.

Umemura, Takeji, Satoru Joshita, Tomoo Yamazaki, et al.. (2016). Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis. Liver International. 37(6). 897–905. 18 indexed citations

20.

Umemura, Takeji, Masao Ôta, Yoshihiko Katsuyama, et al.. (2014). KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Human Immunology. 75(8). 822–826. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact